Therapeutic Potential of Rituximab in Managing Hepatitis C-Associated Cryoglobulinemic Vasculitis: A Systematic Review

(1) Background. Hepatitis C infection often leads to extrahepatic manifestations, including cryoglobulinemic vasculitis. This systematic review aimed to assess the efficacy and safety of rituximab in treating hepatitis C-associated cryoglobulinemic vasculitis. (2) Methods. Following PRISMA guideline...

Descripción completa

Detalles Bibliográficos
Autores principales: Covic, Andreea, Caruntu, Irina Draga, Burlacu, Alexandru, Giusca, Simona Eliza, Covic, Adrian, Stefan, Anca Elena, Brinza, Crischentian, Ismail, Gener
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Systematic Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648453/
https://www.ncbi.nlm.nih.gov/pubmed/37959271
http://dx.doi.org/10.3390/jcm12216806

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10648453/
https://www.ncbi.nlm.nih.gov/pubmed/37959271
http://dx.doi.org/10.3390/jcm12216806

Ejemplares similares